サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1424134

上流バイオプロセス市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：製品タイプ別、ワークフロー別、使用タイプ別、モード別、地域別

Upstream Bioprocessing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Workflow, Usage Type, Mode, and Geography
出版日: | 発行: The Insight Partners | ページ情報: 英文 210 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
上流バイオプロセス市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲：製品タイプ別、ワークフロー別、使用タイプ別、モード別、地域別
出版日: 2024年01月05日
発行: The Insight Partners
ページ情報: 英文 210 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の上流バイオプロセス市場は、2022年の91億7,400万米ドルから、2030年には250億4,600万米ドルに達すると予測されています。2022年から2030年までのCAGRは13.4%と推定されます。

上流バイオプロセス市場の成長を促す主な要因としては、シングルユース・バイオリアクターの商業利用、バイオ医薬品製造のアウトソーシング、製薬・バイオテクノロジー産業の急成長などが挙げられます。しかし、厳しい規制の枠組みが市場の成長を妨げています。

上流バイオプロセス市場の市場機会

上流バイオプロセス市場には技術的進歩の波が押し寄せており、大きな産業機会をもたらしています。これらの進歩には、細胞培養システム、バイオリアクターの設計、プロセスのモニタリング、制御、自動化とデジタル化の統合における革新的な開発が含まれます。2023年9月、Repligen CorporationとSartoriusは統合バイオリアクターシステムを発表しました。RepligenのXCell Alternating Tangential Flow（ATF）上流強化技術がSartorius Biostatの攪拌タンクリアクター（STR）に統合されました。このバイオリアクター技術は、バイオ製薬企業にとって、N灌流と強化シードトレインの適用を容易にするように設計されています。バイオスタットSTRには、統合されたプロセス分析技術と事前に定義された高度な制御レシピを組み合わせたXCell ATFハードウェアおよびソフトウェアモジュールが組み込まれています。このモジュールは、細胞増殖の管理を簡素化し、灌流手順における細胞保持を強化することを目的としており、細胞保持コントロールタワーを別途用意する必要がありません。このような最新の製品は、プロセス効率、拡張性、適応性の向上を特徴としており、バイオ医薬品製造の進化する要求に応えるために極めて重要です。

高度な細胞培養培地処方と次世代バイオリアクター技術は、上流バイオプロセスの最適化に貢献し、より高い製品収率、製品品質の向上、複雑な生物製剤の効率的な生産を可能にしています。高度な分析とリアルタイムのプロセスモニタリングの継続的な統合は、バイオプロセスにおけるデータ主導の意思決定に革命をもたらし、精度とプロセス最適化の機会を促進します。バイオテクノロジーの進歩は、柔軟でモジュール化された製造プラットフォームの開発も促進します。さらに、機械学習、人工知能、予測分析の融合は、予測的バイオプロセスへの道を開き、プロアクティブプロセス制御、品質保証、コスト最適化の機会を解き放つ。このように、上流バイオプロセスの技術的進歩は業界を再形成し、イノベーション、効率性、適応性のための新たな道を提示しています。

上流バイオプロセス市場を阻害する要因

食品医薬品局（FDA）や欧州医薬品庁（EMA）といった規制当局は、製薬メーカーの業務を一貫して厳しく監視しています。そのため、これらの企業は、製造工程や施設の管理・監視を保証するために、現行の適正製造基準（cGMP）や優良試験所基準（GLP）を推進する最新の規制を遵守する義務があります。現在、FDAのCBER規制はシングルユース・バイオリアクターについて言及していません。登録されたプロトコール、要求事項、本ガイダンスの要求事項からの逸脱は、製造業者や外部委託組織によって編成された臨床試験の終了につながる可能性があります。

SUBを使用する際の最大の懸念は、分子が臨床試験において実験室環境と同じ結果をもたらさない可能性があることです。また、SUBの混合メカニズムは、規制の遵守を困難にする可能性があり、そのためSUBの使用が制限されます。例えば、ウェーブタイプのSUBでは、混合原理が揺動運動に限定されるため、不均一な混合となり、エラーの原因となります。したがって、生物製剤の安全性と有効性は、SUBの適用において重大な懸念を引き起こす可能性があります。したがって、バイオテクノロジー産業に関連する厳しい規制がバイオリアクターの需要を高めています。さらに、中国、インド、ブラジルなどの新興国市場では規制の枠組みがないため、上流バイオプロセス市場の成長が阻害されています。

上流バイオプロセス市場セグメント別概要

上流バイオプロセス市場は、製品タイプ別にバイオリアクター・発酵槽、細胞培養培地、フィルター、バッグ・容器、その他に区分されます。バイオリアクター/発酵槽セグメントは、2022年の上流バイオプロセス市場で最大のシェアを占めています。さらに、細胞培養セグメントは2022年から2030年に大きなCAGRを記録すると予測されています。バイオリアクターと発酵槽は、生物学的由来化合物の発現と生産を含む様々な治療やバイオプロセシング用途のために細胞や微生物を培養する中核容器として機能します。これらのシステムは、温度、pH、溶存酸素、撹拌などのパラメーターを正確に制御し、細胞の増殖に最適な環境を提供するように設計されています。これらは、大規模なバイオプロセス操作で細胞や微生物を培養するために不可欠です。

ワークフロー別では、上流バイオプロセス市場は培地調製、細胞培養、細胞分離に分類されます。細胞分離セグメントは、2022年の上流バイオプロセス市場で最大のシェアを占めています。さらに、2022年から2030年にかけて大きなCAGRが記録されると予測されています。細胞分離は、培養物からタンパク質産物（細胞）を分離する初期段階です。バイオリアクターに回収された生成物の量と品質によって、細胞培養を終了するかどうかが決定されるが、これは重要な決定です。

使用タイプ別では、世界の上流バイオプロセス市場はシングルユースとマルチユースに分類されます。2022年の市場では、シングルユース・セグメントが大きなシェアを占めています。同セグメントは、2022年から2030年の上流バイオプロセス市場で大きなCAGRを記録します。上流バイオプロセス市場は、シングルユース技術の広範な採用によって変革的な変化を経験しています。バイオリアクター、バッグ、コネクターを含むシングルユースシステムは、その柔軟性、費用対効果、交差汚染のリスク低減で脚光を浴びています。これらの使い捨てコンポーネントは、従来のステンレス製機器に取って代わり、バイオ生産により俊敏でスケーラブルなアプローチを提供します。シングルユースの動向は、プロセス開発を加速し、洗浄やバリデーションの手間を最小限に抑え、生産工程間の迅速な切り替えを促進します。

上流バイオプロセス市場は、その形態によってインハウスとアウトソーシングに区分されます。2022年には、インハウス・セグメントの市場シェアが大きくなっています。アウトソーシングセグメントは2022～2030年に高いCAGRを記録すると予想されます。自社製造は、バイオ医薬品企業が製造プロセスの管理強化を求めるにつれて、上流バイオプロセス市場で牽引力を増しています。自社内に上流バイオプロセス施設を設置することで、企業は自社のニーズに合わせてプロセスをカスタマイズすることができ、よりカスタマイズされた効率的なアプローチを確保することができます。この動きには、最先端のバイオリアクターや細胞培養システム、関連技術への投資がしばしば伴います。

上流バイオプロセス市場の地域別概要

2022年の上流バイオプロセス世界市場シェアは北米が最大でした。米国は同地域で最大の上流バイオプロセス市場シェアを占め、2022年から2030年に最も高いCAGRを記録すると予測されています。米国はバイオリアクターの最大市場であり、米国の複数の市場プレーヤーが製薬会社やバイオテクノロジー企業向けにバイオリアクターを製造しています。新しいバイオリアクターの発売、地理的拡大戦略、市場プレイヤー間の提携が米国の上流バイオプロセス市場の成長を後押ししています。2023年4月、BioMADEは、米国のバイオ産業製造におけるバイオリアクターの研究と採用におけるギャップの解決に焦点を当てた5つの新規プロジェクトを発表しました。1,050万米ドルの資金提供を約束したこれらのプロジェクトは、エンジニアリング、ハードウェア開発、スケーラビリティにまたがり、経済を加速させる障壁に対処します。これらのプロジェクトは、Schmidt Futuresが支援する先進的なバイオリアクター設計を導入するための技術革新に焦点を当てる。2023年4月、CytivaはX-platformバイオリアクターを発売し、シングルユース製品で上流バイオプロセス業務を簡素化しました。当初、バイオリアクターのサイズは50Lと200Lでした。X-Platformバイオリアクターは、Figurateオートメーション・ソリューション・ソフトウェアを搭載しており、人間工学的な改善、生産能力の向上、サプライチェーン業務の簡素化により、プロセス効率を高めることができます。

主に技術の進歩、柔軟性の向上、運用コストの低下によるバイオ医薬品分野の成長は、米国の上流バイオプロセス市場にも利益をもたらしています。国際貿易局（ITA）によると、米国はバイオ医薬品の最大市場であり、バイオ医薬品研究開発の世界的リーダーです。製薬研究製造者協会（PhRMA）によると、米国企業は世界の医薬品研究開発業務の50％近くを占めており、知的財産権を保有する多くの新薬の開発に成功しています。新規生物製剤の開発が継続的に増加し、その結果、規制当局からより多くの新規分子生物学的製剤（NME）が承認されるようになり、米国における上流バイオプロセス市場の成長機会が生まれています。Chemical &Engineering Newsによると、米国食品医薬品局（FDA）は2022年、2021年、2020年にそれぞれ37、50、53の新規NMEを承認しました。

さらに、臨床試験の結果を改善し、患者の安全性を確保するために、米国の製薬会社やバイオテクノロジー企業が研究開発投資を増やしていることも、米国の上流バイオプロセス市場の成長に寄与しています。さらに、米国政府による投資の増加に伴い、精密医療への関心が高まっていることも、今後数年間の市場成長に寄与するとみられます。

上流バイオプロセス市場に関するレポート作成時に参照した主な一次情報および二次情報には、世界銀行データ、国民保健サービス（NHS）、FDA（食品医薬品局）、EMA（欧州医薬品庁）、WHO（世界保健機関）などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 上流バイオプロセス市場情勢

  • PEST分析

第5章 上流バイオプロセス市場：主要市場力学

  • 上流バイオプロセス市場：主要市場力学
  • 市場促進要因
    • シングルユースバイオリアクターの商業利用
    • バイオ医薬品製造のアウトソーシング
    • 製薬・バイオ産業の急成長
  • 市場抑制要因
    • 厳しい規制枠組み
  • 市場機会
    • 技術の進歩
  • 今後の動向
    • バイオ医薬品業界における研究開発投資の増加
  • 促進要因と抑制要因の影響

第6章 上流バイオプロセス市場：世界市場分析

第7章 上流バイオプロセス市場分析 - 製品タイプ別

  • バイオリアクター/発酵槽
  • 細胞培養
  • フィルター
  • バッグと容器
  • その他

第8章 上流バイオプロセス市場分析 - ワークフロー別

  • 培地調製
  • 細胞培養
  • 細胞分離

第9章 上流バイオプロセス市場分析 - 使用タイプ別

  • シングルユース
  • マルチユース

第10章 上流バイオプロセス市場分析 - モード別

  • インハウス
  • 外部委託

第11章 上流バイオプロセス市場 - 地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他中東・アフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米

第12章 業界情勢

  • 上流バイオプロセス市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte Ltd
  • Cellexus International Ltd
  • Sartorius AG
  • Danaher Corp
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris Inc
  • PBS Biotech Inc

第14章 付録

図表

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 7. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 8. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 9. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 10. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 12. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 13. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 14. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 15. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 16. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 17. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 18. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 19. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 20. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 21. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 22. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 23. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 24. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 25. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 26. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 27. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 28. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 29. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 30. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 31. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 32. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 33. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 34. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 35. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 36. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 37. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 38. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 39. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 40. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 41. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 42. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 43. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 44. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 45. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 46. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 47. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 48. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 49. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 50. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 51. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 52. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 53. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 54. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 55. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 56. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 57. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 58. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 59. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 60. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 61. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 62. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 63. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 64. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 65. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 66. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 67. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 68. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 69. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 70. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 71. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 72. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 73. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 74. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 75. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 76. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 77. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 78. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 79. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 80. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 81. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 82. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 83. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 84. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 85. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 86. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 87. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 88. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 89. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 90. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 91. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 92. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 93. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 94. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 95. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 96. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 97. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 98. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 99. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 100. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 101. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 102. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 103. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 104. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 105. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 106. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 107. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 108. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 109. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 110. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 111. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 112. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 113. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Usage Type
  • Table 114. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Mode
  • Table 115. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Product Type
  • Table 116. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million) - by Workflow
  • Table 117. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 118. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 119. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 120. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
  • Table 121. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Upstream Bioprocessing Market Breakdown, by Geography, 2022 and 2030 (%)
  • Figure 5. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 6. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 12. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 16. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 19. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Upstream Bioprocessing Market Breakdown by Region, 2022 and 2030 (%)
  • Figure 22. North America Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 24. North America: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. US: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 27. Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Europe: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 29. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Europe: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 31. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Asia Pacific: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Thousands)
  • Figure 38. Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Asia Pacific: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 40. China: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 42. India: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 43. Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 44. South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. Middle East & Africa: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Thousands)
  • Figure 47. Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 49. South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 51. UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 53. South and Central America: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Thousands)
  • Figure 54. South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. South and Central America: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 56. Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 57. Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 58. Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. Growth Strategies in Upstream Bioprocessing Market
目次
Product Code: TIPRE00006819

The global upstream bioprocessing market is expected to reach US$ 25.046 billion in 2030 from US$ 9.174 billion in 2022. The market is estimated to grow with a CAGR of 13.4% from 2022 to 2030.

Key factors driving the upstream bioprocessing market growth include the commercial use of single-use bioreactors, outsourcing of biopharmaceutical manufacturing, and rapid growth of pharmaceutical and biotechnology industries. However, a stringent regulatory framework hinders market growth.

Market Opportunities of Upstream Bioprocessing Market

The upstream bioprocessing market is experiencing a wave of technological advancements, presenting considerable industry opportunities. These advancements include innovative developments in cell culture systems, bioreactor design, process monitoring, and control, as well as the integration of automation and digitalization. In September 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system. Repligen's XCell Alternating Tangential Flow (ATF) upstream intensification technology has been integrated into the Sartorius Biostat stirred-tank reactor (STR). This bioreactor technology is designed to make the application of N perfusion and intensified seed train easier for biopharmaceutical firms. An embedded XCell ATF hardware and software module that combines integrated process analytical technologies with predefined advanced control recipes is incorporated into Biostat STR. This module is intended to simplify the management of cell growth and enhance cell retention in perfusion procedures, eliminating the need for a separate cell retention control tower. Such modern products feature enhanced process efficiency, scalability, and adaptability, which are crucial for meeting the evolving demands of biopharmaceutical production.

Advanced cell culture media formulations and next-generation bioreactor technologies are contributing to the optimization of upstream bioprocessing, enabling higher product yields, improved product quality, and the efficient production of complex biologics. The ongoing integration of advanced analytics and real-time process monitoring revolutionizes data-driven decision-making in bioprocessing, driving precision and process optimization opportunities. Progress in biotechnology also fosters the development of flexible and modular manufacturing platforms. Additionally, the convergence of machine learning, artificial intelligence, and predictive analytics is paving the way for predictive bioprocessing, unlocking proactive process control, quality assurance, and cost optimization opportunities. Thus, technological advancements in upstream bioprocessing are reshaping the industry, presenting new avenues for innovation, efficiency, and adaptability.

Factor Hampering Upstream Bioprocessing Market

Regulatory authorities such as the Food & Drug Administration and the European Medicine Agency (EMA) monitor the operations of pharmaceutical manufacturers with consistent stringency. These businesses are thus bound to abide by the updated regulations promoting current good manufacturing practices (cGMP) and good laboratory practices (GLP) for assuring the control and monitoring of manufacturing processes and facilities. Currently, the FDA's CBER regulations do not mention single-use bioreactors. Any diversions from the registered protocols, demands, and requirements of this guidance may lead to the termination of the clinical trials orchestrated by manufacturers or outsourced organizations.

The biggest concern with using SUBs is that the molecules may not generate the same results in clinical trials as they produce in laboratory environments. The mixing mechanisms of SUBs may also lead to difficulties adhering to regulations, which restricts their use. For instance, in wave-type SUBs, the mixing principle is limited to a rocking movement, leading to uneven mixing and causing errors. Hence, the safety and efficacy of biologics may raise significant concerns in the application of SUBs. Therefore, stringent regulations associated with the biotechnology industry bolster the demand for bioreactors. Moreover, the lack of regulatory framework in developing nations such as China, India, and Brazil hinders the upstream bioprocessing market growth.

Upstream Bioprocessing Market: Segmental Overview

Based on product type, the upstream bioprocessing market is segmented into bioreactors and fermenters, cell culture media, filters, bags and containers, and others. The bioreactors/fermenters segment held the largest share of the upstream bioprocessing market in 2022. Moreover, the cell culture segment is anticipated to register a significant CAGR during 2022-2030. Bioreactors and fermenters serve as core vessels in which cells and microorganisms are grown for various therapeutic and bioprocessing applications involving the expression and production of biologically derived compounds. These systems are engineered to provide an optimal environment for cell growth, incorporating precise control over parameters such as temperature, pH, dissolved oxygen, and agitation. These are critical for cultivating cells and microorganisms in large-scale bioprocessing operations.

Based on workflow, the upstream bioprocessing market is classified into media preparation, cell culture, and cell separation. The cell separation segment held the largest share of the upstream bioprocessing market in 2022. It is further anticipated that a significant CAGR will be registered from 2022 to 2030. Cell separation is the initial stage of segregating protein products (cells) from the culture. The amount and quality of the product collected in the bioreactors will determine whether to terminate the cell culture, which is an important decision.

Based on usage type, the global upstream bioprocessing market is classified into single use and multi-use. The single-use segment held a larger share of the market in 2022. The same segment will record a significant CAGR in the upstream bioprocessing market during 2022-2030. The upstream bioprocessing market has experienced a transformative shift with the widespread adoption of single-use technologies. Single-use systems, including bioreactors, bags, and connectors, have gained prominence for their flexibility, cost-effectiveness, and reduced risk of cross-contamination. These disposable components replace traditional stainless-steel equipment, offering a more agile and scalable approach to bioproduction. The single-use trend accelerates process development, minimizes cleaning and validation efforts, and facilitates quick changeovers between production runs.

The upstream bioprocessing market is segmented into in-house and outsourced based on mode. In 2022, the in-house segment held a larger market share. The outsourced segment is expected to record a higher CAGR during 2022-2030. In-house manufacturing is gaining traction in the upstream bioprocessing market as biopharmaceutical companies seek greater control over their production processes. Establishing in-house upstream bioprocessing facilities enables companies to tailor processes to their needs, ensuring a more customized and efficient approach. This move often involves investment in state-of-the-art bioreactors, cell culture systems, and associated technologies.

Upstream Bioprocessing Market: Geographical Overview

North America accounted for the largest global upstream bioprocessing market share in 2022. The US held the largest upstream bioprocessing market share in the region and is anticipated to register the highest CAGR during 2022-2030. The US is the largest market for bioreactors-several market players in the US manufacture bioreactors for pharmaceutical and biotechnology companies. Launch of new bioreactors, geographic expansion strategies, and partnerships among market players bolster the upstream bioprocessing market growth in the US. In April 2023, BioMADE announced five new projects focused on addressing gaps in the US' research and adoption of bioreactors in bio-industrial manufacturing. With a funding commitment of US$ 10.5 million, these projects would span engineering, hardware development, and scalability to address the barriers to accelerating an economy. These projects would focus on innovation to introduce advanced bioreactor designs supported by Schmidt Futures. In April 2023, Cytiva launched X-platform bioreactors to simplify upstream bioprocessing operations with single-use products. Initially, bioreactors were available in 50 L and 200 L sizes. The X-Platform bioreactors are equipped with Figurate automation solution software, and they can increase process efficiency through ergonomic improvements, production capacity, and simplified supply chain operations.

The growth of the biopharmaceutical sector, mainly due to technological advancements, increasing flexibility, and low operational costs, also benefits the upstream bioprocessing market in the US. As per the International Trade Administration (ITA), the US is the largest market for biopharmaceuticals and the global leader in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), companies in the US account for nearly 50% of the global pharmaceutical R&D work, and they have succeeded in developing many novel medicines for which they hold intellectual property rights. A continuous increase in the development of new biologics, resulting in the approval of more new molecular entities (NME) by regulatory authorities, creates opportunities for the growth of the upstream bioprocessing market in the US. According to the Chemical & Engineering News, the US Food and Drug Administration (FDA) approved ~37, 50, and 53 new NMEs in 2022, 2021, and 2020, respectively.

Furthermore, Increasing R&D investments by US-based pharmaceutical and biotechnology companies to improve outcomes of clinical trials and ensure patient safety contributes to the growth of the upstream bioprocessing market in the US. In addition, growing traction toward precision medicine with rising investments by the US government will likely contribute to market growth in the coming years.

A few of the major primary and secondary sources referred to while preparing the report on the upstream bioprocessing market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the upstream bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global upstream bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.  
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the upstream bioprocessing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Upstream Bioprocessing Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Commercial Use of Single-Use Bioreactors
    • 5.2.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.2.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.3 Market Restraints
    • 5.3.1 Stringent Regulatory Framework
  • 5.4 Market Opportunities
    • 5.4.1 Technological Advancements
  • 5.5 Future Trends
    • 5.5.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.6 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Global Market Analysis

7. Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Upstream Bioprocessing Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Upstream Bioprocessing Market Overview
    • 11.2.2 North America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.2.2.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.2.2.2 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.2.2.3 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.2.2.4 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.2.3 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 North America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.2 US
      • 11.2.3.3 US: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.3.1 US: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.2.3.3.2 US: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.2.3.3.3 US: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.2.3.3.4 US: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.2.3.4 Canada
      • 11.2.3.5 Canada: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.5.1 Canada: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.2.3.5.2 Canada: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.2.3.5.3 Canada: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.2.3.5.4 Canada: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.2.3.6 Mexico
      • 11.2.3.7 Mexico: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.7.1 Mexico: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.2.3.7.2 Mexico: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.2.3.7.3 Mexico: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.2.3.7.4 Mexico: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.3 Europe
    • 11.3.1 Overview
    • 11.3.2 Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.3.2.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.3.2.2 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.3.2.3 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.3.2.4 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.3.3 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.2 UK
      • 11.3.3.3 UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.3.1 UK: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.3.2 UK: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.3.3 UK: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.3.4 UK: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.4 Germany
      • 11.3.3.5 Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.5.1 Germany: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.5.2 Germany: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.5.3 Germany: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.5.4 Germany: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.6 France
      • 11.3.3.7 France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.7.1 France: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.7.2 France: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.7.3 France: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.7.4 France: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.8 Italy
      • 11.3.3.9 Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.9.1 Italy: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.9.2 Italy: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.9.3 Italy: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.9.4 Italy: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.10 Spain
      • 11.3.3.11 Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.11.1 Spain: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.11.2 Spain: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.11.3 Spain: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.11.4 Spain: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.3.3.12 Rest of Europe
      • 11.3.3.13 Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.13.1 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.3.3.13.2 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.3.3.13.3 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.3.3.13.4 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.4 Asia Pacific
    • 11.4.1 Overview
    • 11.4.2 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.4.2.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.4.2.2 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.4.2.3 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.4.2.4 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.4.3 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Asia Pacific: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.2 China
      • 11.4.3.3 China: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.3.1 China: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.3.2 China: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.3.3 China: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.3.4 China: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.4 Japan
      • 11.4.3.5 Japan: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.5.1 Japan: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.5.2 Japan: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.5.3 Japan: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.5.4 Japan: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.6 India
      • 11.4.3.7 India: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.7.1 India: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.7.2 India: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.7.3 India: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.7.4 India: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.8 Australia
      • 11.4.3.9 Australia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.9.1 Australia: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.9.2 Australia: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.9.3 Australia: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.9.4 Australia: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.10 South Korea
      • 11.4.3.11 South Korea: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.11.1 South Korea: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.11.2 South Korea: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.11.3 South Korea: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.11.4 South Korea: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.4.3.12 Rest of APAC
      • 11.4.3.13 Rest of APAC: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.13.1 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.4.3.13.2 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.4.3.13.3 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.4.3.13.4 Rest of APAC: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.5 Middle East and Africa
    • 11.5.1 Overview
    • 11.5.2 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.5.2.1 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.5.2.2 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.5.2.3 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.5.2.4 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.5.3 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.2 South Africa
      • 11.5.3.3 South Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.3.1 South Africa: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.3.2 South Africa: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.3.3 South Africa: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.3.4 South Africa: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.5.3.4 Saudi Arabia
      • 11.5.3.5 Saudi Arabia: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.5.1 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.5.2 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.5.3 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.5.4 Saudi Arabia: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.5.3.6 UAE
      • 11.5.3.7 UAE: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.7.1 UAE: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.7.2 UAE: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.7.3 UAE: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.7.4 UAE: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.5.3.8 Rest of Middle East and Africa
      • 11.5.3.9 Rest of Middle East and Africa: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.9.1 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.5.3.9.2 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.5.3.9.3 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.5.3.9.4 Rest of Middle East and Africa: Upstream Bioprocessing Market Breakdown, by Mode
  • 11.6 South and Central America
    • 11.6.1 Overview
    • 11.6.2 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.6.2.1 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Product Type
      • 11.6.2.2 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Workflow
      • 11.6.2.3 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Usage Type
      • 11.6.2.4 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Mode
    • 11.6.3 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.1 South and Central America: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.2 Brazil
      • 11.6.3.3 Brazil: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.3.1 Brazil: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.6.3.3.2 Brazil: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.6.3.3.3 Brazil: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.6.3.3.4 Brazil: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.6.3.4 Argentina
      • 11.6.3.5 Argentina: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.5.1 Argentina: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.6.3.5.2 Argentina: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.6.3.5.3 Argentina: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.6.3.5.4 Argentina: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.6.3.6 Rest of South and Central America
      • 11.6.3.7 Rest of South and Central America: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.6.3.7.1 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.6.3.7.2 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.6.3.7.3 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.6.3.7.4 Rest of South and Central America: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Cellexus International Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Danaher Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Getinge AB
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Merck KGaA
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Corning Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Entegris Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 PBS Biotech Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms